Updates, insights & stories about pharma
May 05, 2022
How can generics manufacturers unlock more business opportunities
The market for generic drugs around the world is only going to grow. At the moment, we see varying market penetration rates across Europe and other developed markets, but due to market trends, in a decade or so, generic penetration across developed markets may well amount to around 80-90%.
Mar 24, 2022
Pipelinepharma records quadruple growth over a single year
Marketplaces are a standard staple for many B2B industries. By connecting buyers and sellers in the digital realm, marketplaces significantly reduce dealmaking time and effort. Europe alone lists more than 1700 online marketplaces, with more than 30% aimed at business-to-business transactions.
Mar 02, 2022
Urgent call for medicines in Ukraine
At Pipelinepharma we stand united with the people of Ukraine. We are calling upon our contacts to support the urgent needs of medicines in Ukraine. With your help, together we can save lives and ensure the continuity of healthcare services for the Ukrainian people.
Feb 20, 2022
Cooperative buying to help launch new medicines in small markets
Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world.
Nov 23, 2021
Pharmaceutical companies shift to near-shore medicines sourcing
With global supply chains under stress due to the COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. The number of requests for commercial proposals from European distributors when drug manufacturers are also based in Europe has increased by 69% in 2021, compared to the previous year.